CO6220944A2 - Composicion anestesica nanoparticulada para la administracion topica - Google Patents

Composicion anestesica nanoparticulada para la administracion topica

Info

Publication number
CO6220944A2
CO6220944A2 CO09114245A CO09114245A CO6220944A2 CO 6220944 A2 CO6220944 A2 CO 6220944A2 CO 09114245 A CO09114245 A CO 09114245A CO 09114245 A CO09114245 A CO 09114245A CO 6220944 A2 CO6220944 A2 CO 6220944A2
Authority
CO
Colombia
Prior art keywords
poly
anesthetic composition
amino
anesthetic
hydroxybutyrates
Prior art date
Application number
CO09114245A
Other languages
English (en)
Inventor
Alario Junior Dante
Guterres Silvia Stanisçuaski
Zancan Lali Ronsini
Pohlmann Adriana Raffin
Original Assignee
Biolab Sanus Farmaceutica Ltda
Univ Fed Di Rio Grande Do Sul Ufrgs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39765309&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6220944(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biolab Sanus Farmaceutica Ltda, Univ Fed Di Rio Grande Do Sul Ufrgs filed Critical Biolab Sanus Farmaceutica Ltda
Publication of CO6220944A2 publication Critical patent/CO6220944A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1.- Composición anestésica para la administración tópica sobre la piel o mucosas CARACTERIZADA PORQUE comprende por lo menos un agente anestésico local en nanopartículas poliméricas en una cantidad terapéuticamente eficaz y por lo menos un agente que aumenta la viscosidad. 2.- La composición anestésica, de acuerdo con la reivindicación 1, CARACTERIZADA PORQUE los polimeros utilizados en la producción de las nanopartículas pueden ser seleccionados del grupo constituido por: poli (e-caprolactona); copolímeros del ácido metacrílico y de ésteres acrílicos o metacrílicos; poli (metacrilato de alquilo); poli (metacrilato de metilo), poli (láctico), poli (Iáctico-glicólico), poli (glicólico), poli (caprolactona), poli (amidas), poli (anhídridos), poli (aminoácidos), poli (ésteres), poli (cianoacrilatos), poli (fosfacenos), poli (fostoésteres), poli (esteramidas), poli (dioxanonas), poli (acetales), poli (cetales), poli (carbonatos), poli (ortocarbonatos), poli (uretanos) degradables, quitinas, quitosana, poli (hidroxibutiratos), poli (hidroxivaleratos), poli (ácido málico), poli (alquilenooxalatos), poli (alquilenosuccinatos), poli (hidroxibutiratos-co-hidroxivaleratos), y copolímeros terpolímeros, celulosa oxidada, o combinaciones o mezclas de estos materiales. 3.- La composición anestésica, de acuerdo con la reivindicación 1 o 2, CARACTERIZADA PORQUE los agentes anestésicos locales se pueden seleccionar del grupo que consiste en: éster de benzoato o amino-éster, anilida amino-amida, naftoato amino-éster, ácido benzoico, pramoxina, diclonina, mexiletina, lidocaína, prilocaína, bupivacaína, mepivocaína, etidocaína, butanilcaína, trimecaína, tetracaína, benzocaína, ropivacaína, dibucaína, procaína, clorprocaína, butambeno, picrato, dibucaína, articaína e xilocaína, y sus sales, derivados o mezclas.
CO09114245A 2007-03-16 2009-10-14 Composicion anestesica nanoparticulada para la administracion topica CO6220944A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0700832A BRPI0700832B8 (pt) 2007-03-16 2007-03-16 composição anestésica tópica compreendendo suspensão de nanocápsulas poliméricas de lidocaína e prilocaína

Publications (1)

Publication Number Publication Date
CO6220944A2 true CO6220944A2 (es) 2010-11-19

Family

ID=39765309

Family Applications (1)

Application Number Title Priority Date Filing Date
CO09114245A CO6220944A2 (es) 2007-03-16 2009-10-14 Composicion anestesica nanoparticulada para la administracion topica

Country Status (15)

Country Link
US (1) US8568788B2 (es)
EP (1) EP2134334B1 (es)
JP (1) JP5496684B2 (es)
AR (1) AR065723A1 (es)
BR (1) BRPI0700832B8 (es)
CL (1) CL2008000728A1 (es)
CO (1) CO6220944A2 (es)
EC (1) ECSP099691A (es)
ES (1) ES2804466T3 (es)
HU (1) HUE051155T2 (es)
MX (1) MX2009009853A (es)
PE (2) PE20081883A1 (es)
PL (1) PL2134334T3 (es)
PT (1) PT2134334T (es)
WO (1) WO2008113144A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0913809B1 (pt) 2008-10-02 2019-02-05 Mylan Inc método para produzir continuamente um laminado adesivo sensível á pressão multicamada
BR102012022036B1 (pt) * 2012-08-31 2019-10-01 Biolab Sanus Farmacêutica Ltda. Nanopartícula polimérica de finasterida e minoxidil, processo de sua preparação, suspensão aquosa contendo a mesma, composição farmacêutica, e seu uso
BR102014028009B1 (pt) 2014-11-10 2023-04-18 Universidade Federal De Pelotas Composições filmogênicas para bioadesivos anestésicos tópicos (bats) para liberação controlada de princípios ativos e bioadesivos anestésicos tópicos
US11452700B2 (en) 2017-08-04 2022-09-27 Eric Haas Method of delivering an anesthetic agent and glucocorticoid micro and nano bioerodible particles
CN113244167B (zh) * 2021-05-20 2022-11-29 河北科技大学 一种盐酸利多卡因凝胶及其制备方法
RU208882U1 (ru) * 2021-08-25 2022-01-19 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курская государственная сельскохозяйственная академия имени И.И. Иванова" Раневая атравматическая повязка для животных

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7713618L (sv) * 1977-12-01 1979-06-02 Astra Laekemedel Ab Lokalanestetisk blandning
FR2659554B1 (fr) * 1990-03-16 1994-09-30 Oreal Composition pour le traitement cosmetique et/ou pharmaceutique des couches superieures de l'epiderme par application topique sur la peau et procede de preparation correspondant.
DE4120760A1 (de) * 1991-06-24 1993-03-04 3 M Medica Gmbh Traegersysteme fuer arzneimittel
JPH09255565A (ja) * 1996-03-26 1997-09-30 Daikyo Yakuhin Kogyo Kk 皮膚局所麻酔用ヒドロゲルパッチ
WO1999001114A1 (en) * 1997-07-02 1999-01-14 Euro-Celtique, S.A. Prolonged anesthesia in joints and body spaces
US5993836A (en) * 1998-04-28 1999-11-30 Castillo; James G. Topical anesthetic formulation
KR100463167B1 (ko) * 2001-04-13 2004-12-23 주식회사 태평양 고분자 나노입자를 이용한 경피흡수제 및 이를 함유한외용제 조성물
US20070154527A1 (en) * 2001-10-12 2007-07-05 Monosoirx, Llc Topical film compositions for delivery of actives
US20080124400A1 (en) * 2004-06-24 2008-05-29 Angiotech International Ag Microparticles With High Loadings Of A Bioactive Agent
AU2005299748B2 (en) * 2004-10-21 2009-04-09 Tgel Bio Co., Ltd In situ controlled release drug delivery system
WO2006091719A2 (en) * 2005-02-23 2006-08-31 Sontra Medical Corporation Compositions and methods enhancing transdermal delivery of drugs and biologics

Also Published As

Publication number Publication date
BRPI0700832B1 (pt) 2017-12-26
PE20081883A1 (es) 2008-12-27
BRPI0700832A (pt) 2008-11-04
EP2134334B1 (en) 2020-05-13
US8568788B2 (en) 2013-10-29
HUE051155T2 (hu) 2021-03-01
PE20131337A1 (es) 2013-11-18
ES2804466T3 (es) 2021-02-08
JP2010521498A (ja) 2010-06-24
MX2009009853A (es) 2010-02-18
PL2134334T3 (pl) 2021-03-08
WO2008113144A1 (en) 2008-09-25
AR065723A1 (es) 2009-06-24
ECSP099691A (es) 2010-02-26
PT2134334T (pt) 2020-08-20
EP2134334A4 (en) 2013-04-24
US20100086614A1 (en) 2010-04-08
BRPI0700832B8 (pt) 2021-05-25
CL2008000728A1 (es) 2008-09-26
EP2134334A1 (en) 2009-12-23
JP5496684B2 (ja) 2014-05-21

Similar Documents

Publication Publication Date Title
CO6220944A2 (es) Composicion anestesica nanoparticulada para la administracion topica
AR085128A1 (es) Composicion de acido hialuronico
AR063621A1 (es) Matriz polimerica insoluble en agua para la administracion de farmacos
AR057685A1 (es) Estructuras no tejidas de baja densidad y metodos de fabricacion de las mismas
BRPI0813680A8 (pt) composição compreendendo um agente de irna para alfa-enac, constituído por um fita senso e uma fita antissenso, e seu uso
DK1715865T3 (da) Terapeutisk middel mod hyperlipæmi med pitavastatiner og eicosapentaensyre
BR112012012997A2 (pt) ''microesfera biodegradável, material para utilização em conexão com o tratamento de feridas compreendendo microesferas,curativos de ferida, método para a realização de hemostasia, método para realização do tratamento de uma ferida, método para cultura de células in vitro e método para a realização de embolização vascular"
MX339787B (es) Una solución para fijar cateteres que tiene propiedades antimicrobianas y anticoagulantes.
TWI255838B (en) Biodegradable film having honeycomb structure, adhesion resistant material made of the film and process for producing the film and the adhesion resistant material
CA2299950A1 (en) Oral adhesive sheet and oral adhesive preparation
UY31699A1 (es) Suspensiones de acetonido de triamcinolona de baja viscosidad y elevada floculacion para inyeccion intravitrea
AR070614A1 (es) Microesferas polimericas como aditivos biodegradables contra perdida de fluido en aplicaciones de campo petrolero
PE20180575A1 (es) Benzamidas sustituidas y metodos para utilizarlas
JP2009185061A5 (es)
PL2167623T3 (pl) Kompozycja detergentu zawierająca współsurfaktanty wzmacniające pienienie oraz powierzchniowo czynne polimery stabilizujące pienienie
ATE464002T1 (de) Verlängerungen für chirurgischen retraktor
CL2003002277A1 (es) Composicion farmaceutica inyectable, de deposito de liberacion prolongada, que comprende un agente beneficioso disuelto o disperso en un gel constituido por un polimero bioerosionable y biocompatible; y un solvente.
JP2007516776A5 (es)
NO20032850L (no) Gjennomhullet polymerfilmbane med diol/surfaktantadditiv
RU2008110780A (ru) Зубная лента
DE602006016127D1 (de) Zusammensetzung und dosierform mit einer festen oder halbfesten matrix
CR20120133A (es) Composiciën de entrega de agente activo atrapado en carbohidrato y articulos que usan el mismo
AR094290A1 (es) Composiciones y metodos para la administracion transdermica de agentes antiinflamatorios no esteroideos
BR112017004071A2 (pt) artigo termoplástico com agente ativo
CY1108069T1 (el) Φαρμακευτικη συνθεση σε μορφη υδρογελης για διαδερμικη χορηγηση δραστικων ουσιων

Legal Events

Date Code Title Description
FC Application refused